A potentially common peptide target in secreted heat shock protein-90α for hypoxia-inducible factor-1α-positive tumors

Molecular Biology of the Cell

Volumn 23, Issue 4, 2012, Pages 602-613

  Sahu, Divya ^a   Zhao, Zhengwei ^a,b   Tsen, Fred ^a   Cheng, Chieh Fang ^a   Park, Ryan ^a   Situ, Alan J ^a   Dai, Jinyao ^a   Eginli, Ariana ^a   Shams, Sharmineh ^a   Chen, Mei ^a   Ulmer, Tobias S ^a   Conti, Peter ^a   Woodley, David T ^a   Li, Wei ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 ALPHA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INVASION; CARCINOGENESIS; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION;

ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CELL LINE, TUMOR; CELL MOVEMENT; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASMS; PEPTIDES; RNA, SMALL INTERFERING;

EID: 84863118967     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-06-0575     Document Type: Article

References (49)

1. Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, Bunn HF, Livingston DM (1996). An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA 93, 12969-12973. (Pubitemid 26382753)
2. Basu S, Binder RJ, Ramalingam T, Srivastava PK (2001). CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14, 303-313. (Pubitemid 32289294)
3. Bertout JA, Patel SA, Simon MC (2008). The impact of O2 availability on human cancer. Nat Rev Cancer 8, 967-975.
4. Cailleau R, Young R, Olive M, Reeves WJ Jr (1974). Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53, 661-674.
5. Chen B, Piel WH, Gui L, Bruford E, Monteiro A (2005). The HSP90 family of genes in the human genome: insights into their divergence and evolution. Genomics 86, 627-637. (Pubitemid 41752943)
6. Chen JS, Hsu YM, Chen CC, Chen LL, Lee CC, Huang TS (2010). Secreted heat shock protein 90alpha induces colorectal cancer cell invasion through CD91/LRP-1 and NF-kappaB-mediated integrin alphaV expression. J Biol Chem 285, 25458-25466.
7. Cheng CF et al. (2008). Transforming growth factor alpha (TGFalpha)-stimulated secretion of HSP90alpha: using the receptor LRP-1/CD91 to promote human skin cell migration against a TGFbeta-rich environment during wound healing. Mol Cell Biol 28, 3344-3358.
8. Cheng CF, Fan J, Zhao Z, Woodley DT, Li W (2010). Secreted heat shock protein-90alpha: a more effective and safer target for anti-cancer drugs? Curr Signal Transduct Ther 5, 121-127.
9. Csermely P, Schnaider T, Soti C, Prohaszka Z, Nardai G (1998). The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol Ther 79, 129-168. (Pubitemid 28380440)
10. Dales JP, Garcia S, Meunier-Carpentier S, Andrac-Meyer L, Haddad O, Lavaut MN, Allasia C, Bonnier P, Charpin C (2005). Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients. Int J Cancer 116, 734-739. (Pubitemid 41099705)
11. Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ (2000). Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113, 3365-3374.
12. Eustace BK et al. (2004). Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat Cell Biol 6, 507-514. (Pubitemid 38786593)
13. Gaffney EV (1982). A cell line (HBL-100) established from human breast milk. Cell Tissue Res 227, 563-568.
14. Gill SC, Vonhippel PH (1989). Calculation of protein extinction coefficients from amino-acid sequence data. Anal Biochem 182, 319-326. (Pubitemid 19277112)
15. Gopal U, Bohonowych JE, Lema-Tome C, Liu A, Garrett-Mayer E, Wang B, Isaacs JS (2011). A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion. PLoS One 8, e17649.
16. Grenert JP et al. (1997). The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation. J Biol Chem 272, 23843-23850. (Pubitemid 27410964)
17. Herz J, Strickland DK (2001). LRP: a multifunctional scavenger and signaling receptor. J Clin Invest 108, 779-784. (Pubitemid 32880284)
18. Hutchison GJ, Valentine HR, Loncaster JA, Davidson SE, Hunter RD, Roberts SA, Harris AL, Stratford IJ, Price PM, West CM (2004). Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix. Clin Cancer Res 10, 8405-8412. (Pubitemid 40053403)
19. Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC, Burrows FJ (2003). A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 425, 407-410. (Pubitemid 37187270)
20. Kuroita T, Tachibana H, Ohashi H, Shirahata S, Murakami H (1992). Growth stimulating activity of heat shock protein 90 alpha to lymphoid cell lines in serum-free medium. Cytotechnology 8, 109-117.
21. Lee CC, Lin TW, Ko TP, Wang AH (2011). The hexameric structures of human heat shock protein 90. PLoS One 6, e19961.
22. Li W, Henry G, Fan J, Bandyopadhyay B, Pang K, Garner W, Chen M, Woodley DT (2004). Signals that initiate, augment, and provide directionality for human keratinocyte motility. J Invest Dermatol 123, 622-633. (Pubitemid 39281601)
23. Li W, Li Y, Guan S, Fan J, Cheng CF, Bright AM, Chinn C, Chen M, Woodley DT (2007). Extracellular heat shock protein-90alpha: linking hypoxia to skin cell motility and wound healing. EMBO J 26, 1221-1233. (Pubitemid 46398702)
24. Li W, Sahu D, Tsen F (2011). Secreted heat shock protein-90 (Hsp90) in wound healing and cancer. Biochim Biophys Acta Sep 25 [Epub ahead of print].
25. Lobley A, Whitmore L, Wallace BA (2002). DICHROWEB: an interactive website for the analysis of protein secondary structure from circular dichroism spectra. Bioinformatics 18, 211-212. (Pubitemid 34145057)
26. Lundgren K, Holm C, Landberg G (2007). Hypoxia and breast cancer: prognostic and therapeutic implications. Cell Mol Life Sci 64, 3233-3247.
27. Majmundar AJ, Wong WJ, Simon MC (2010). Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40, 294-309.
28. Milani M, Harris AL (2008). Targeting tumour hypoxia in breast cancer. Eur J Cancer 44, 2766-2773.
29. Neckers L, Neckers K (2002). Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents. Expert Opin Emerg Drugs 7, 277-288. (Pubitemid 35291458)
30. Poon E, Harris AL, Ashcroft M (2009). Targeting the hypoxia-inducible factor (HIF) pathway in cancer. Expert Rev Mol Med 11, e26.
31. Provencher SW, Glockner J (1981). Estimation of globular protein secondary structure from circular-dichroism. Biochemistry 20, 33-37.
32. Rosman DS, Kaklamani V, Pasche B (2007). New insights into breast cancer genetics and impact on patient management. Curr Treat Options Oncol 8, 61-73.
33. Semenza GL (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3, 721-732.
34. Sidera K, Gaitanou M, Stellas D, Matsas R, Patsavoudi E (2008). A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2. J Biol Chem 283, 2031-2041.
35. Sidera K, Samiotaki M, Yfanti E, Panayotou G, Patsavoudi E (2004). Involvement of cell surface HSP90 in cell migration reveals a novel role in the developing nervous system. J Biol Chem 279, 45379-45388. (Pubitemid 39491521)
36. Solit DB, Chiosis G (2008). Development and application of Hsp90 inhibitors. Drug Discov Today 13, 38-43.
37. Song H, Li Y, Lee J, Schwartz AL, Bu G (2009). Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9. Cancer Res 69, 879-886.
38. Stellas D, El Hamidieh A, Patsavoudi E (2010). Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits. BMC Cell Bio 5, 51.
39. Supko JG, Hickman RL, Grever MR, Malspeis L (1995). Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent. Cancer Chemother Pharmacol 36, 305-315.
40. Suzuki S, Kulkarni AB (2010). Extracellular heat shock protein HSP90beta secreted by MG63 osteosarcoma cells inhibits activation of latent TGF-beta1. Biochem Biophys Res Commun 39, 525-531.
41. Trepel J, Mollapour M, Giaccone G, Neckers L (2010). Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 10, 537-549.
42. Tsutsumi S, Neckers L (2007). Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis. Cancer Sci 98, 1536-1539. (Pubitemid 47308447)
43. Tsutsumi S, Scroggins B, Koga F, Lee MJ, Trepel J, Felts S, Carreras C, Neckers L (2008). A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene 27, 2478-2487. (Pubitemid 351521101)
44. Wang XX, Song W, Zhuo Y, Fu H, Shi Y, Liang M, Tong G, Chang Y Luo (2009). The regulatory mechanism of Hsp90alpha secretion and its function in tumor malignancy. Proc Natl Acad Sci USA 106, 21288-21293.
45. Welch WJ, Feramisco JR (1982). Purification of the major mammalian heat shock proteins. J Biol Chem 257, 14949-14959.
46. Whitmore L, Wallace BA (2004). DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res 32, W668-W673. (Pubitemid 38997420)
47. Whitesell L, Mimnaugh EG, De Costa B, Myers CE, Neckers LM (1994). Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci USA 91, 8324-8328.
48. Woodley DT, Fan J, Cheng CF, Li Y, Chen M, Bu G, Li W (2009). Participation of the lipoprotein receptor LRP1 in hypoxia-HSP90alpha autocrine signaling to promote keratinocyte migration. J Cell Sci 122, 1495-1498.
49. Zhou L, Yan C, Gieling RG, Kida Y, Garner W, Li W, Han YP (2009). Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated kinase-1. BMC Immunol 10, 15.